Global Webcast – New Treatments for Progressive MS

Tune into our Facebook page on February 22 at 11am ET, to view this global webcast presented by the International Progressive MS Alliance. Hosted by Kathy Smith, an MS volunteer and advocate who was diagnosed with MS in 2004, you will hear from leading MS experts about the current state of treatments for progressive MS, active clinical trials that may provide new solutions, and research efforts to develop breakthrough treatments to ultimately end MS progression. 

Webcast Panel 

Professor Robert Fox, MD is the Chair of the Scientific Steering Committee of the International Progressive MS Alliance. He serves as Staff Neurologist at the Mellen Center for Multiple Sclerosis, Vice-Chair for Research at the Neurological Institute, Cleveland Clinic, and Professor of Neurology at Cleveland Clinic Lerner College of Medicine. Dr Fox’s research interests focus on clinical trials in multiple sclerosis, innovative MRI techniques to evaluate tissue recovery after injury and the effects of MS treatments, as well as MS patient decision-making and tolerance to risk. He has published more than 200 peer-reviewed papers, book chapters, and books. 

Don Mahad, MD, PhD is Senior Clinical Lecturer and Honorary Consultant Neurologist at the University of Edinburgh, UK. His research is focused on bioenergetic changes in progressive multiple sclerosis patients as well as experimental disease modes, particularly the role of mitochondria. His research group explores the potential consequences of mitochondrial dysfunction and energy failure for the clinical presentation of progressive MS. Findings from his work are driving the discovery of potential neuroprotective drugs for treating progressive MS. He is a recipient of an Alliance Challenges in Progressive MS Award and has written numerous papers. 

Clare Walton, PhD is Head of Research at the MS Society in the UK where she looks after their research funding program and strategic projects related to MS prevention, research capacity building, and symptom management research. Clare’s field of expertise is in neural stem cells and brain repair and she has spent the last decade working in non-profit organizations across a range of neurological conditions. 

About the International Progressive MS Alliance  

The International Progressive MS Alliance is a first-of-its-kind global research network aimed at accelerating the development of new, effective treatments for progressive MS through an unprecedented collaboration of MS organizations, researchers, healthcare professionals, pharmaceutical companies, trusts, foundations, donors and people affected by MS.